Drug DiscoveryApprovalsInflammation May 21, 2024 Teva and Alvotech launch SIMLANDI in US for arthritis By PBR Staff Writer This marks the first biosimilar launched under the strategic partnership between the two companies. SIMLANDI has been approved by the US Food and Drug Administration (FDA) as the
Drug Discovery May 20, 2024 ERS Genomics and IRBM sign deal for CRISPR technology By PBR Staff Writer With this agreement, IRBM will be able to leverage CRISPR/Cas9 technology to advance its drug discovery processes. The editing technology will also be integrated into the comprehensive drug
Production & SalesManufacturing May 17, 2024 Sol-Gel, Beimei sign deal for TWYNEO commercialisation By PBR Staff Writer TWYNEO is claimed to be the first and only US Food and Drug Administration (FDA)-approved fixed-dose cream which combines tretinoin and benzoyl peroxide for treating acne vulgaris in
Manufacturing May 16, 2024 Scorpius announces validation of microbial facilities By PBR Staff Writer The latest milestone means that the company’s microbial cleanrooms are now qualified for the production of cGMP microbial biologic drugs. The validation of Scorpius’ microbial cleanrooms has already
Research & Development May 15, 2024 FogPharma and ARTBIO collaborate to co-develop new cancer therapies By PBR Staff Writer The collaboration will combine FogPharma’s Helicon peptide platform with ARTBIO’s AlphaDirect platform to create targeted therapies using the 212Pb isotope. The companies will jointly develop HEARTs against multiple
Research & DevelopmentManufacturing May 14, 2024 PharmaLogic launches new radiopharmaceutical facility in New York, US By PBR Staff Writer The company initially acquired the site in 2022 and extensively renovated it. The Bronx facility is equipped with latest technology and marks a significant investment by PharmaLogic in
Drug DiscoveryClinical TrialsMetabolic Disorders May 10, 2024 Aardvark Therapeutics secures $85m in Series C funding round By PBR Staff Writer The funding attracted a diverse group of new investors, including Cormorant Asset Management, SymBiosis, Surveyor Capital, Walleye Capital, Laurion Capital Management, Tetragon Financial Group, LG Technology Ventures, Cantor
ManufacturingPharmaceuticals and Healthcare May 9, 2024 IMA Life to build new pharma freeze-drying equipment production site By PBR Staff Writer This expansion, announced by New York Governor Kathy Hochul, is supported by New York State through the state’s economic development agency, Empire State Development (ESD). The state government
OncologyHaematology May 8, 2024 ImmunoACT and Caring Cross sign TriCAR-T cell therapy development deal By PBR Staff Writer The collaboration is set to address the issue of relapse in patients undergoing treatment with conventional anti-CD19 CAR T-cell therapies through the use of TriCAR-T immunotherapy. As per
OncologyDrug Discovery May 7, 2024 OverT Bio secures $16m in seed funding for cell therapy development By PBR Staff Writer The funding round was led jointly by ARTIS Ventures and Wing VC, with contributions from a consortium of investors including Alexandria Venture Investments, Fusion Fund, OMX Ventures, Civilization